Investor Relations. Latest. April 24, 2024 Invitae ... OTC: NVTA 0.00 -0.00 -72.22% Volume: 178,541 20m ... Investor Toolkit. Invitae's Third Quarter 2023 ...
People also ask
Is Invitae getting acquired?
Is Invitae filing for bankruptcies?
What is going on with Nvta?
What analysts are saying about Invitae?
Investor Relations. Home»News & Events ... Presentation. (opens in new window). August 8, 2023 ... OTC: NVTA 0.00 +0.00 +16.13% Volume: 279,073 20 minute delay ...
Mar 6, 2024 · PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced estimated unaudited fourth quarter and full year ...
Find annual and quearterly earnings data for NVTA (NVTA) including earnings per share, earnings forecasts at Nasdaq.com.
Rating
(975)
In the last quarter Invitae reported -$0.31 EPS in relation to ― expected by the market ... NVTA Earnings History ... investors and does not represent returns that ...
Access Invitae Corporation (NVTA) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using Quartr.
$0.02
Get the latest insights on NVTA (NVTA) with press releases and corporate news to help you in your trading and investing decisions.
Feb 6, 2024 · Investor Relations ir@invitae.com. NYSE Contact: NYSE Communications PublicRelations-NYSE@ice.com. Source: NYSE Regulation. View all news ...